AMAALA
9.6.2020 10:02:13 CEST | Business Wire | Press release
AMAALA, the ultra-luxury destination located along Saudi Arabia’s northwestern coast, appointed Saudi Arabian Parsons Limited (Parsons), who, following a competitive tender, was awarded the construction supervision contract. The digitally enabled solutions provider is taking on the role of engineer, supervising the execution of works currently underway across Phase I of Triple Bay.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200609005322/en/
Binyah, a Saudi Real Estate Infrastructure Company, joins Parsons onsite carrying out the excavation, backfilling, and earthworks required to achieve the formation levels and grading of Phase I of the Triple Bay masterplan.
Chief Executive Officer of AMAALA, Nicholas Naples said: "We are delighted to work with two prestigious firms on a project of this scale. We are very pleased with the progress to date and have welcomed the expertise and experience both Parsons and Binyah have brought to the development of the destination. We celebrated a milestone moment in our history when work onsite began, and we are looking forward to working closely together to bring our vision for Triple Bay to life. Together we will deliver an ultra-luxury destination for future generations around the globe, nested in the long-term vision of the Kingdom of Saudi Arabia."
AMAALA’s environmental team is guiding Parsons and Binyah on the AMAALA site to oversee all stages of development, ensuring work is being carried out within its sustainability and environmental guidelines.
Commenting on the signing, Managing Director of Saudi Arabian Parsons Limited, Ken Murray, said: "As an iconic development in the Kingdom, AMAALA is set to become a preeminent destination for travellers from the world over. Parsons is thrilled to join the delivery team, and we look forward to supporting the Triple Bay development and continue our proud participation in the delivery of Vision 2030 for Saudi Arabia."
Chief Executive Officer of Binyah, Eng. Fahad Al-Mesfir stated: "The agreement marked a strategic turning point for the company, given it’s the first business agreement with AMAALA to implement the preparatory works. Binyah is working to provide the highest quality standards in the implementation of the project, which will contribute to achieving the ambitions of the Kingdom’s 2030 vision."
Set in the Prince Mohammed bin Salman Nature Reserve across three unique communities, AMAALA will bring to life the desires and ambitions of a community passionate about shaping and living transformative moments. AMAALA’s trio of communities – Triple Bay, The Coastal Development, and The Island – will showcase three different sets of experiences for guests.
- Triple Bay will offer a fully holistic wellness retreat, state-of-the-art diagnostic medical facilities and authentic treatments designed to feature the local environment. Triple Bay will also be home to a fully integrated sports and entertainment community.
- The Costal Development is set to become the defining hub of contemporary art in the Middle East, playing host to a dynamic programme of exciting events from the global arts and cultural calendar.
- The Island will be the tranquil home of an exclusive art community, and an Arabic botanical garden bestrewn with sculptural pieces.
With a focus on creating transformative personal journeys inspired by arts, wellness and the purity of the Red Sea, AMAALA will allow travellers to immerse themselves in the finest wellness, arts, culture, sports and fitness offerings, redefining the luxury tourism experience.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20200609005322/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom